I Bank

Summary

Affiliation: Academic Medical Center
Country: The Netherlands

Publications

  1. ncbi request reprint Absolute annual incidences of first events of venous thromboembolism and arterial vascular events in individuals with elevated FVIII:c. A prospective family cohort study
    Ivan Bank
    Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Thromb Haemost 98:1040-4. 2007
  2. ncbi request reprint Social aspects of genetic testing for factor V Leiden mutation in healthy individuals and their importance for daily practice
    Ivan Bank
    Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, F4 277, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    Thromb Res 113:7-12. 2004
  3. ncbi request reprint Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study
    Ivan Bank
    Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Arch Intern Med 164:1932-7. 2004
  4. ncbi request reprint Acquired and inherited thrombophilic factors and the risk for residual venous thrombosis
    Ivan Bank
    Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Pathophysiol Haemost Thromb 33:192-6. 2003
  5. ncbi request reprint Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis
    I Bank
    Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    J Thromb Haemost 3:79-84. 2005
  6. ncbi request reprint A prospective cohort study on the absolute incidence of venous thromboembolism and arterial cardiovascular disease in asymptomatic carriers of the prothrombin 20210A mutation
    Michiel Coppens
    Department of Vascular Medicine F4 276, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    Blood 108:2604-7. 2006
  7. ncbi request reprint Treatment of venous thromboembolism with vitamin K antagonists: patients' health state valuations and treatment preferences
    Mirjam Locadia
    Department of Medical Psychology J3 219, Academic Medical Centre, University of Amsterdam, PO Box 22700, 1100 DE Amsterdam, The Netherlands
    Thromb Haemost 92:1336-41. 2004
  8. ncbi request reprint Unselected women with elevated levels of factor VIII:C or homocysteine are not at increased risk for obstetric complications
    Saskia Middeldorp
    Academic Medical Center, Department of Vascular Medicine, F4 276, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands
    Thromb Haemost 92:787-90. 2004
  9. ncbi request reprint Protein S type III deficiency is no risk factor for venous and arterial thromboembolism in 168 thrombophilic families: a retrospective study
    Eduard J Libourel
    Department of Hematology, Division of Hemostasis, Thrombosis and Rheology, University Hospital, Groningen, The Netherlands
    Blood Coagul Fibrinolysis 16:135-40. 2005
  10. ncbi request reprint The risk of venous and arterial thrombosis in hyperhomocysteinaemia is low and mainly depends on concomitant thrombophilic defects
    Willem M Lijfering
    Division of Haemostasis, Thrombosis and Rheology, Department of Hematology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
    Thromb Haemost 98:457-63. 2007

Detail Information

Publications11

  1. ncbi request reprint Absolute annual incidences of first events of venous thromboembolism and arterial vascular events in individuals with elevated FVIII:c. A prospective family cohort study
    Ivan Bank
    Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Thromb Haemost 98:1040-4. 2007
    ..Elevated FVIII:c may be a common risk factor for both clinical entities...
  2. ncbi request reprint Social aspects of genetic testing for factor V Leiden mutation in healthy individuals and their importance for daily practice
    Ivan Bank
    Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, F4 277, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    Thromb Res 113:7-12. 2004
    ..Any guideline to be developed for the screening for FVL should take this into account too...
  3. ncbi request reprint Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study
    Ivan Bank
    Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Arch Intern Med 164:1932-7. 2004
    ..The aim of this study was to estimate the incidences of first venous and arterial thrombotic events and pregnancy-related complications in relatives of patients with the mutation...
  4. ncbi request reprint Acquired and inherited thrombophilic factors and the risk for residual venous thrombosis
    Ivan Bank
    Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Pathophysiol Haemost Thromb 33:192-6. 2003
    ..7, 95% CI 1.2-2.2). Although these results should be confirmed in a larger study, they might help us form hypotheses concerning why patients with thrombophilia are more prone to recurrent venous thromboembolic disease...
  5. ncbi request reprint Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis
    I Bank
    Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    J Thromb Haemost 3:79-84. 2005
    ....
  6. ncbi request reprint A prospective cohort study on the absolute incidence of venous thromboembolism and arterial cardiovascular disease in asymptomatic carriers of the prothrombin 20210A mutation
    Michiel Coppens
    Department of Vascular Medicine F4 276, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
    Blood 108:2604-7. 2006
    ....
  7. ncbi request reprint Treatment of venous thromboembolism with vitamin K antagonists: patients' health state valuations and treatment preferences
    Mirjam Locadia
    Department of Medical Psychology J3 219, Academic Medical Centre, University of Amsterdam, PO Box 22700, 1100 DE Amsterdam, The Netherlands
    Thromb Haemost 92:1336-41. 2004
    ..Due to the substantial and unpredictable variability in valuations and treatment preferences, recommendations regarding treatment duration should be tailored to patients' specific values and concerns...
  8. ncbi request reprint Unselected women with elevated levels of factor VIII:C or homocysteine are not at increased risk for obstetric complications
    Saskia Middeldorp
    Academic Medical Center, Department of Vascular Medicine, F4 276, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands
    Thromb Haemost 92:787-90. 2004
    ..Unselected women with elevated plasma levels of FVIII:C or hyperhomocysteinemia are not at increased risk for obstetric complications as compared to their relatives with normal levels...
  9. ncbi request reprint Protein S type III deficiency is no risk factor for venous and arterial thromboembolism in 168 thrombophilic families: a retrospective study
    Eduard J Libourel
    Department of Hematology, Division of Hemostasis, Thrombosis and Rheology, University Hospital, Groningen, The Netherlands
    Blood Coagul Fibrinolysis 16:135-40. 2005
    ..10 per 100 person-years (95% CI, 0.05-0.19) [hazard ratio, 1.5 (95% CI, 0.3-6.0)]. These results suggest that protein S deficiency type III is not associated with an increased risk of either venous or arterial thromboembolism...
  10. ncbi request reprint The risk of venous and arterial thrombosis in hyperhomocysteinaemia is low and mainly depends on concomitant thrombophilic defects
    Willem M Lijfering
    Division of Haemostasis, Thrombosis and Rheology, Department of Hematology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
    Thromb Haemost 98:457-63. 2007
    ..Concomitant thrombophilic defects are probably main determinants on the risk of venous thrombosis, rather than hyperhomocysteinaemia itself...
  11. ncbi request reprint Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism
    Eduard J Libourel
    Division of Hemostasis, Thrombosis and Rheology, University Hospital Groningen, The Netherlands
    Haematologica 87:1068-73. 2002
    ..Our aim was to assess the contributions of high levels of factor VIII:C, factor XI:C, thrombin activatable fibrinolysis inhibitor (TAFI) and lipoprotein (a) (Lp(a)) to the risk of venous thromboembolism in factor V Leiden carriers...